UBS OCONNOR LLC - Q1 2013 holdings

Add to watchlist

$5.59 Billion is the total value of UBS OCONNOR LLC's 672 reported holdings in Q1 2013. The portfolio turnover from Q4 2012 to Q1 2013 was 90.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
VMED NewVIRGIN M$151,851,000,000–3,100,900
+100.0%
39.05%–
CVH BuyCOVENTRY$99,790,000,000
+6.0%
2,121,846
+1.0%
25.66%
-19.3%
S SellSPRINT N$54,864,000,000
-4.8%
8,834,874
-13.0%
14.11%
-27.5%
GDI NewGARDNER$39,212,000,000–522,069
+100.0%
10.08%–
PXP SellPLAINS E$22,748,000,000
-21.6%
479,211
-22.5%
5.85%
-40.3%
MMR BuyMCMORAN$12,779,000,000
+14.6%
781,545
+12.5%
3.29%
-12.7%
WMS NewWMS INDS$7,576,000,000–300,514
+100.0%
1.95%–
NXY ExitNEXEN INcall$0–-439,300
-100.0%
-0.23%–
NYX ExitNYSE EUR$0–-55,908
-100.0%
-0.60%–
CLWR ExitCLEARWIRcla$0–-3,193,637
-100.0%
-3.12%–
ExitCLEARWIRcla$0–-3,193,637
-100.0%
-3.12%–
SHS ExitSAUER-DA$0–-238,356
-100.0%
-4.30%–
NXY ExitNEXEN IN$0–-2,617,567
-100.0%
-23.81%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2013-04-24
  • View 13F-HR/A filed 2013-11-14
  • View 13F-HR/A filed 2014-02-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
META PLATF36Q3 20232.3%
SPDR S&P 533Q3 20230.7%
ACTIVISION29Q3 202371.3%
AMAZON COM29Q3 20230.8%
GAMING & L29Q3 20230.8%
SPDR S&P29Q1 20230.1%
DISNEY W28Q3 20212.0%
POST HLD27Q2 20201.8%
GENERAL27Q3 20221.4%
CAMDEN PPT27Q3 20230.6%

View UBS OCONNOR LLC's complete holdings history.

Latest significant ownerships (13-D/G)
UBS OCONNOR LLC Q1 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HERON THERAPEUTICS, INC. /DE/Sold outFebruary 13, 202300.0%
MAGELLAN HEALTH INCSold outFebruary 13, 202300.0%
New Providence Acquisition Corp. IIFebruary 13, 20232,227,5008.9%
Nuance Communications, Inc.Sold outFebruary 13, 202300.0%
SCP & CO Healthcare Acquisition CoSold outFebruary 13, 202300.0%
ACORDA THERAPEUTICS INCSold outFebruary 14, 202200.0%
Amryt Pharma plcFebruary 14, 20229,950,0003.1%
Evolv Technologies Holdings, Inc.February 14, 20221,547,3111.1%
GreenSky, Inc.February 14, 2022698,5530.8%
GTY Technology Holdings Inc.February 14, 2022758,0001.3%

View UBS OCONNOR LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR2024-02-14
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12

View UBS OCONNOR LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (5593285000.0 != 388820000000.0)
  • The reported number of holdings is incorrect (672 != 7)
  • The reported has been amended

Export UBS OCONNOR LLC's holdings

CSVXLS